NuVasive Clinical Services Revenue and Competitors

Columbia, MD USA

Location

N/A

Total Funding

Medical

Industry

Estimated Revenue & Valuation

  • NuVasive Clinical Services's estimated annual revenue is currently $125.2M per year.(i)
  • NuVasive Clinical Services's estimated revenue per employee is $476,046

Employee Data

  • NuVasive Clinical Services has 263 Employees.(i)
  • NuVasive Clinical Services grew their employee count by 4% last year.

NuVasive Clinical Services's People

NameTitleEmail/Phone
1
EVP and Chief Financial Officer (CFO)Reveal Email/Phone
2
Chief Commercial Officer, President OrthopedicsReveal Email/Phone
3
Co Owner Care4surgeryReveal Email/Phone
4
VP, CommercialReveal Email/Phone
5
Zone VP-North CentralReveal Email/Phone
6
VP Mid AtlanticReveal Email/Phone
7
VP - NortheastReveal Email/Phone
8
VP Human ResourcesReveal Email/Phone
9
VP Tax and TreasuryReveal Email/Phone
10
Executive Assistant to Massimo Calafiore, SVP, Global Implant Systems and GM, NSOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$180M3785%N/AN/A
#2
$1.7M442%N/AN/A
#3
$125.2M2634%N/AN/A
#4
$0.2M50%N/AN/A
#5
$7.5M8732%N/AN/A
#6
$7.5M12228%N/AN/A
#7
$2.5M1110%N/AN/A
#8
$7.5M39-15%$78.9MN/A
#9
$5.6M21-28%$19.4MN/A
#10
$16.4M4845%N/AN/A
Add Company

What Is NuVasive Clinical Services?

NCS is committed to providing hospitals, surgeons, and patients a best-in-class IOM experience. NCS combines industry-leading technology, service, and quality to serve over 100,000 cases annually. Our team of board-certified neurologists and neurophysiologists are highly trained professionals aiming to provide the highest-quality intraoperative neuromonitoring service possible and is supported by an industry-leading training and educational program.

keywords:N/A

N/A

Total Funding

263

Number of Employees

$125.2M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$125.2M2634%N/A
#2
$37.2M26649%N/A
#3
$52.7M266N/AN/A
#4
$97.6M2692%N/A
#5
$74.5M2701%N/A